Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;18(5):286.
doi: 10.1038/s41575-021-00445-1.

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD

Katrina Ray  1
Affiliations
Comment

Antibody responses to SARS-CoV-2 infection are attenuated in infliximab-treated patients with IBD

Katrina Ray. Nat Rev Gastroenterol Hepatol. 2021 May.
No abstract available

PubMed Disclaimer

Comment on

  • Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
    Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421

References

    1. Kennedy NA, et al. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Gut. 2021 doi: 10.1136/gutjnl-2021-324388. - DOI - PubMed